VIVOTEK's consolidated sales revenues for March 2024 totaled USD $19.62 million, representing a 51.35 percent increase as compared to USD $12.96 million for February 2024 and a 15.46 percent decrease as compared to USD $23.2 million for March 2023.

The Company's cumulative consolidated sales revenues from January to March in 2024 were USD $49.84 million, a 37.59 percent decrease as compared to USD $79.86 million for the same period in 2023.